These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 27373800)
1. Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects. Ma J; Wang Q; Yang X; Hao W; Huang Z; Zhang J; Wang X; Wang PG Dalton Trans; 2016 Jul; 45(29):11830-8. PubMed ID: 27373800 [TBL] [Abstract][Full Text] [Related]
2. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation. Wang H; Yang X; Zhao C; Wang PG; Wang X Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077 [TBL] [Abstract][Full Text] [Related]
3. Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo. Ma J; Yang X; Hao W; Huang Z; Wang X; Wang PG Eur J Med Chem; 2017 Mar; 128():45-55. PubMed ID: 28147308 [TBL] [Abstract][Full Text] [Related]
4. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery. Ma J; Wang Q; Huang Z; Yang X; Nie Q; Hao W; Wang PG; Wang X J Med Chem; 2017 Jul; 60(13):5736-5748. PubMed ID: 28603992 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents. Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024 [TBL] [Abstract][Full Text] [Related]
6. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer. Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543 [TBL] [Abstract][Full Text] [Related]
7. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related]
8. New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo. Song XQ; Ma ZY; Wu YG; Dai ML; Wang DB; Xu JY; Liu Y Eur J Med Chem; 2019 Apr; 167():377-387. PubMed ID: 30784875 [TBL] [Abstract][Full Text] [Related]
9. Enhanced potency of a chloro-substituted polyaromatic platinum(II) complex and its platinum(IV) prodrug against lung cancer. Baz J; Khoury A; Elias MG; Mansour N; Mehanna S; Hammoud O; Gordon CP; Taleb RI; Aldrich-Wright JR; Daher CF Chem Biol Interact; 2024 Jan; 388():110834. PubMed ID: 38103879 [TBL] [Abstract][Full Text] [Related]
10. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates. Liu R; Fu Z; Zhao M; Gao X; Li H; Mi Q; Liu P; Yang J; Yao Z; Gao Q Oncotarget; 2017 Jun; 8(24):39476-39496. PubMed ID: 28467806 [TBL] [Abstract][Full Text] [Related]
11. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate. Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Platinum Liu W; Yu C; Wang M; He Y; Guo Z; He J; Jiang R; Xu Q; Liang J; Wang S J Med Chem; 2023 Jun; 66(12):8066-8085. PubMed ID: 37306362 [TBL] [Abstract][Full Text] [Related]
14. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Thiabaud G; McCall R; He G; Arambula JF; Siddik ZH; Sessler JL Angew Chem Int Ed Engl; 2016 Oct; 55(41):12626-31. PubMed ID: 27377046 [TBL] [Abstract][Full Text] [Related]
15. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment. Wang Z; Deng Z; Zhu G Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents. Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191 [TBL] [Abstract][Full Text] [Related]